# Ocugen (OCGN) — Earnings

OCGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ocgn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.07 |
| EPS estimate | −$0.05 |
| EPS surprise | −31.33% |
| Revenue surprise | +67.41% |
| Revenue | $1.5M |
| Revenue estimate | $888,833.00 |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1372299/000162828026054057/ocgn-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/33f99fa8-d386-697d-34f3-51ad99a1678a.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.05 | −$0.07 | -31.33% | $888,833.00 | $1.5M |
| Q1 2026 | May 5, 2026 | −$0.05 | −$0.06 | -16.73% | $417,833.00 | $1.5M |
| Q4 2025 | Mar 4, 2026 | −$0.06 | −$0.06 | -2.56% | $1.4M | — |
| Q3 2025 | Nov 5, 2025 | −$0.06 | −$0.07 | -25.00% | $550,000.00 | $1.8M |
| Q2 2025 | Aug 1, 2025 | −$0.06 | −$0.05 | 10.71% | $466,667.00 | $1.4M |
| Q1 2025 | May 9, 2025 | −$0.06 | −$0.05 | 13.04% | — | $1.5M |
| Q4 2024 | Mar 5, 2025 | −$0.05 | −$0.05 | 4.76% | $400,000.00 | $764,000.00 |
| Q3 2024 | Nov 8, 2024 | −$0.06 | −$0.05 | 9.09% | $400,000.00 | $1.1M |
| Q2 2024 | Aug 8, 2024 | −$0.05 | −$0.04 | 24.95% | — | $1.1M |
| Q1 2024 | May 14, 2024 | −$0.06 | −$0.05 | 21.01% | — | $1.0M |
| Q4 2023 | Apr 2, 2024 | −$0.07 | −$0.03 | 53.85% | — | $1.4M |
| Q3 2023 | Nov 9, 2023 | −$0.07 | −$0.06 | 14.29% | — | — |
| Q2 2023 | Aug 21, 2023 | −$0.07 | −$0.10 | -42.86% | — | — |
| Q1 2023 | May 5, 2023 | −$0.11 | −$0.07 | 35.19% | — | — |
| Q4 2022 | Feb 28, 2023 | −$0.10 | −$0.10 | 0.00% | $2.2M | — |
| Q3 2022 | Nov 8, 2022 | −$0.10 | −$0.10 | -1.73% | — | — |
| Q2 2022 | Aug 5, 2022 | −$0.08 | −$0.09 | -18.42% | — | — |
| Q1 2022 | May 6, 2022 | $0.01 | −$0.09 | -776.69% | $13.9M | — |
| Q4 2021 | Feb 25, 2022 | −$0.07 | −$0.07 | -7.69% | — | — |
| Q3 2021 | Nov 9, 2021 | −$0.04 | −$0.05 | -25.00% | — | — |

## Frequently Asked Questions

### When did Ocugen (OCGN) last report earnings?

Ocugen last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did OCGN beat earnings estimates?

No. Ocugen reported EPS of −$0.07 for Q2 2026 against a −$0.05 estimate — a 31.33% miss.

### How much revenue did OCGN report last quarter?

Ocugen reported $1.5M in revenue for Q2 2026, against a consensus estimate of $888,833.00.

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).